Cargando…

Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial

INTRODUCTION: Carnosine, an over-the-counter food supplement, has a promising potential for the prevention and treatment of chronic diseases such as type 2 diabetes (T2DM), cardiovascular and neurodegenerative diseases through its anti-inflammatory, antiglycation, antioxidative and chelating effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baye, Estifanos, Menon, Kirthi, de Courten, Maximilian PJ, Earnest, Arul, Cameron, James, de Courten, Barbora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588946/ https://www.ncbi.nlm.nih.gov/pubmed/28864708 http://dx.doi.org/10.1136/bmjopen-2017-017691

Ejemplares similares

Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial
por: Menon, Kirthi, et al.
Publicado: (2021)

Shared Medical Appointments May Be Effective for Improving Clinical and Behavioral Outcomes in Type 2 Diabetes: A Narrative Review
por: Menon, Kirthi, et al.
Publicado: (2017)

The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes
por: Menon, Kirthi, et al.
Publicado: (2022)

Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial
por: Saadati, Saeede, et al.
Publicado: (2023)

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial
por: Baye, Estifanos, et al.
Publicado: (2017)

Effects of supplementation with carnosine and other histidine-containing dipeptides on chronic disease risk factors and outcomes: protocol for a systematic review of randomised controlled trials
por: Menon, Kirthi, et al.
Publicado: (2018)

Author Correction: Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial
por: Baye, Estifanos, et al.
Publicado: (2020)

Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans
por: de Courten, Barbora, et al.
Publicado: (2015)

Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
por: Baye, Estifanos, et al.
Publicado: (2018)

Nutritional Interventions for COVID-19: A Role for Carnosine?
por: Feehan, Jack, et al.
Publicado: (2021)

Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials
por: Baye, Estifanos, et al.
Publicado: (2017)

Geographical variation of diabetic emergencies attended by prehospital Emergency Medical Services is associated with measures of ethnicity and socioeconomic status
por: Villani, Melanie, et al.
Publicado: (2018)

Time series modelling to forecast prehospital EMS demand for diabetic emergencies
por: Villani, Melanie, et al.
Publicado: (2017)

Associations between Urinary Advanced Glycation End Products and Cardiometabolic Parameters in Metabolically Healthy Obese Women
por: Baye, Estifanos, et al.
Publicado: (2019)

Anti-Cancer Effects of Carnosine—A Dipeptide Molecule
por: Prakash, Monica D., et al.
Publicado: (2021)

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial
por: de Courten, Barbora, et al.
Publicado: (2015)

Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial
por: de Courten, Barbora, et al.
Publicado: (2015)

Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study
por: Kawahara, Tetsuya, et al.
Publicado: (2016)

The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence
por: Schön, Martin, et al.
Publicado: (2019)

The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial
por: Larsen, Emil List, et al.
Publicado: (2017)

Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study
por: Bolou, Angeliki, et al.
Publicado: (2023)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial
por: Mousa, Aya, et al.
Publicado: (2017)

Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial
por: Hjortkjær, Henrik Øder, et al.
Publicado: (2016)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
por: Smits, Mark M, et al.
Publicado: (2015)

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
por: Sidelmann Christensen, Alexander, et al.
Publicado: (2018)

Altered Gut Microbiota Composition Is Associated With Back Pain in Overweight and Obese Individuals
por: Dekker Nitert, Marloes, et al.
Publicado: (2020)

Estimating the benefits of obesity prevention on productivity: an Australian perspective
por: Menon, Kirthi, et al.
Publicado: (2022)

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial
por: Johansen, Nicklas Järvelä, et al.
Publicado: (2018)

Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3)
por: Xie, Yun, et al.
Publicado: (2023)

Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
por: Naderpoor, Negar, et al.
Publicado: (2017)

Erratum: Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
por: Naderpoor, Negar, et al.
Publicado: (2018)

Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol
por: Rajeev, Surya Panicker, et al.
Publicado: (2017)

BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
por: Bönhof, Gidon J, et al.
Publicado: (2022)

Personalising activity to target peak hyperglycaemia and improve cardiometabolic health in people with type 2 diabetes: protocol for a randomised controlled trial
por: Chang, Courtney R, et al.
Publicado: (2022)

The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial
por: Foghsgaard, Signe, et al.
Publicado: (2013)

Husbands’ participation in birth preparedness and complication readiness plan in Kucha district, Gamo Zone, Southern Ethiopia
por: Gultie, Teklemariam, et al.
Publicado: (2021)

Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover study
por: Hjortkær, Henrik, et al.
Publicado: (2014)

Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial
por: Ibrahim, Ibrahim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pd30mcrl2clkavc90e4lp4ajn1